"/> Tocris Bioscience™ Gefitinib-based PROTAC™ 3 | B-LABO France

Tocris Bioscience™ Gefitinib-based PROTAC™ 3

Réf. : BL-RE-151632Réf. fabricant : 18798546 5 mg
436,27 € HT

Potent EGFR PROTAC™

Nom chimique ou matériau
(2 S,4 R)-1-(-2-(3-(2-((5-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
CAS
2230821-27-7
Quantité
5 mg
Cible
Active Degraders
Formule moléculaire
C47H57ClFN7O8S
Marque
Tocris Bioscience

Gefitinib-based PROTAC® 3 is a potent EGFR PROTAC™ Degrader. Comprises an EGFR inhibitor gefitinib (Iressa Cat.No. 3000) conjugated to a VHL ligand via a linker. Induces EGFR degradation (DC50 values are 11.7 nM and 22.3 nM in HCC827 (exon 19 del) and H3255 (L858R mutation) cells, respectively). Exhibits no degradation of wild-type EGFR at concentrations up to 10 μM.

PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.

Caractéristiques techniques

MarqueTocris Bioscience
Réf. B-LABOBL-RE-151632
Réf. fabricant18798546
Nom chimique ou matériau(2 S,4 R)-1-(-2-(3-(2-((5-((4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)pentyl)oxy)ethoxy)propanamido)-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide
CAS2230821-27-7
Quantité5 mg
CibleActive Degraders
Formule moléculaireC<sub>47</sub>H<sub>57</sub>ClFN<sub>7</sub>O<sub>8</sub>S
Pureté0.98
Une question, une configuration particulière ?
Contactez-nous pour un devis.
Demander un devis 03 65 67 15 79

Produits similaires

Tocris Bioscience&trade;&nbsp;BAY 805

Tocris Bioscience™ BAY 805

174,94 € HT
Tocris Bioscience&trade;&nbsp;BAY 805

Tocris Bioscience™ BAY 805

174,94 € HT
Tocris Bioscience&trade;&nbsp;RNB 61

Tocris Bioscience™ RNB 61

236,49 € HT
Tocris Bioscience&trade;&nbsp;IBG3

Tocris Bioscience™ IBG3

231,10 € HT